Organs are composed of multiple cell types, which require proper intercellular communication for development and homeostasis. The behavior of the cells is strongly influenced by cell-cell junctions, which constitute structural bridges between cells that have critical roles in tissue stability, homeostasis and signaling.
The structures of the individual proteins that build up these junctions are largely known, although the molecular arrangement responsible for their many functions remains elusive. The blood-brain barrier (BBB) is the most prominent entity that relies on selective cell-cell junctions acting as a barrier to control the transport of substances across the central nervous system and maintaining brain homeostasis.
BBB function is built on a specific arrangement of multiple cell types: endothelial cells form the vascular walls and are surrounded by mural cells (smooth muscle cells and pericytes), both of which are ensheathed in the basal lamina (Fig. 2); and projections of astrocytes, called astrocytic endfeet, encircle the brain vasculature and mediate communication between the vascular and nervous systems.
One level, the paracellular route, relies on the proper assembly of endothelial cell junctions (tight junctions and adherens junctions) between adjacent endothelial cells to impair the passage of molecules through the intercellular space (Stamatovic et al., 2016). Defects in cell-cell junction proteins lead to BBB impairment and leakage, which allows the paracellular passage of substances and blood cells – an outcome or an aggravating factor in neuropathologies (Sweeney et al., 2019). Conversely, the possibility of pharmacologically manipulating the opening of the BBB by temporally loosening the endothelial junction assembly could allow therapeutic access to the central nervous system.
